Disease-A-Month
Volume 54, Issue 8 , Pages 540-546 , August 2008

Management of Bronchiectasis

References 

  1. Barker AF. Bronchiectasis. N Engl J Med. 2002;346:1383–1393
  2. O'Donnell AE, Barker AF, Ilowite JS, et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Chest. 1998;113:1329–1334
  3. Pang JA, Cheng A, Chan D, et al. The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage. Am Rev Respir Dis. 1989;139:14–17
  4. Angrill J, Agusti C, de Celis R, et al. Bacterial colonization in patients with bronchitectasis: microbial pattern and risk factors. Thorax. 2002;57:15–19
  5. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent Administration of Inhaled Tobramycin in patients with cystic fibrosis. New Engl J Med. 1999;340:23–30
  6. Bilton D, Henig N, Morrissey B, et al. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Chest. 2006;130:1503–1510
  7. Ferkol T, Rosenfeld M, Milla CE. Cystic fibrosis pulmonary exacerbations. J Pediatr. 2006;148:259–264
  8. Wilson CB, Jones PW, O'Leary CJ, et al. Effect of sputum bacteriology on the quality of life of patient with bronchiectasis. Eur Respir J. 1997;10:1754–1760
  9. Ho PL, Chan KN, Ip MSM, et al. The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest. 1998;114:1594–1598
  10. Rayner CF, Tillotson G, Cole PJ, et al. Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis. J Antimicrob Chemother. 1994;34:149–156
  11. Evans DJ, Bara AI, Greenstone M. Prolonged antibiotics for purulent bronchiectasis in children and adults. Cochrane Database of Systematic Reviews. 2007;(2):CD001392. DOI:10.1002/14651858.CD001392.pub2
  12. Saiman L, Marshall BC, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa. JAMA. 2003;290:1749–1756
  13. Davies G, Wilson R. Prophylactic antibiotic treatment of bronchiectasis with azithormycin. Thorax. 2004;59:540–541
  14. Barker AF, Couch L, Fiel SB, et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med. 2000;162:481–485
  15. McCool FD, Rosen MJ. Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(suppl):250S–259S
  16. Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev. 2006;(2):CD002996
  17. Daviskas E, Anderson SD, Eberl S, et al. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. Am J Respir Crit Care Med. 1999;159:1843–1848
  18. Rosen MJ. Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(suppl):122S–131S
  19. Tsang KW, Tan KC, Ho PL, et al. Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax. 2005;60:239–243
  20. Kolbe J, Wells A, Ram FS. Inhaled steroids for bronchiectasis. Cochrane Database Syst Rev. 2000;(2):CD000996
  21. Tsang KW, Ho PL, Lam WK, et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am J Respir Crit Care Med. 1998;158:723–727
  22. Balkanli K, Genc O, Dakak M, et al. Surgical management of bronchiectasis: analysis and short-term results in 238 patients. Eur J Cardiothorac Surg. 2003;24:699–702
  23. Yankaskas JR, Mallory GB Consensus Committee. Lung transplantation in cystic fibrosis: consensus conference statement. Chest. 1998;113:217–226
  24. Beirne PA, Banner NR, Khaghani A, et al. Lung transplant for non-cystic fibrosis bronchiectasis: analysis of a 13-year experience. J Heart Lung Transplant. 2005;24:1530–1535
  25. Flume PA, Yankaskas JR, Ebeling M, et al. Massive hemoptysis in cystic fibrosis. Chest. 2005;128:729–738
  26. McGuinness G, Beacher JR, Harkin TJ, et al. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest. 1994;105:1155–1162
  27. Mal H, Rullon I, Mellot F, et al. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest. 1999;115:996–1001
  28. Fujimoto T, Hillejan L, Stamatis G. Current strategy for surgical management of bronchiectasis. Ann Thorac Surg. 2001;72:1711–1715
  29. Li AM, Sonnappa S, Lex C, et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management?. Eur Respir J. 2005;26:8–14
  30. Elborn JS, Bell SC. Pulmonary exacerbations in cystic fibrosis and bronchiectasis. Thorax. 2007;62:288–290

 The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the United States Government.

PII: S0011-5029(08)00056-4

doi: 10.1016/j.disamonth.2008.05.003

Disease-A-Month
Volume 54, Issue 8 , Pages 540-546 , August 2008

Article Tools